Advisory Panel

(credit: AP Photo/David Grubbs)

FDA Panel Votes Against Avastin For Breast Cancer Treatment

In a decision that could affect millions of women, a Food and Drug Administration advisory panel found that the best-selling cancer drug in the world should not be used on breast cancer patients.

06/29/2011

Follow

Get every new post delivered to your Inbox.

Join 2,538 other followers